HK:2493 Stock Latest News
Company AnnouncementsMabwell Issues Unaudited PRC-Standard Q3 2026 Results and Cautions Investors5d ago2493
Company AnnouncementsMabwell Showcases Promising ADC Breast Cancer Data as 9MW2821 Advances Across Pivotal Trials2w ago2493
Company AnnouncementsMabwell Schedules Board Meeting to Approve Third-Quarter Results2w ago2493- Company AnnouncementsMabwell Shareholders Back SynuSight Deals and Business Scope Change1M ago2493
- Company AnnouncementsMabwell Reports Positive COPD Data for 9MW1911 Ahead of ERS 20261M ago2493
Company AnnouncementsMabwell Narrows Interim Loss as Revenue Surges in First Half of 20262M ago2493Company AnnouncementsMabwell Calls Extraordinary Meeting to Approve SynuSight Deals and Business Scope Change2M ago2493
Company AnnouncementsMabwell Sets Board Meeting to Approve 2026 Interim Results2M ago2493- Company AnnouncementsMabwell Wins NMPA Nod to Test First-in-Class Autoimmune Antibody 9MW5211 in PBC3M ago2493
Company AnnouncementsMabwell Wins NMPA Nod to Test Novel Autoimmune Antibody 9MW5211 in Vitiligo3M ago2493- Company AnnouncementsMabwell Wins NMPA Nod for Type 1 Diabetes Trial of Novel Antibody Drug3M ago2493
Company AnnouncementsMabwell Wins NMPA Green Light for Novel Autoimmune Antibody 9MW52114M ago2493Company AnnouncementsMabwell Wins NMPA Nod for First-in-Class LILRB4/CD3 T Cell Engager in Blood Cancers4M ago2493
Company AnnouncementsMabwell reshapes senior leadership to bolster pharma growth and governance4M ago2493
Company AnnouncementsMabwell Showcases Promising Nectin-4 ADC Data in Cervical Cancer at ESMO Gynae 20264M ago2493
Company AnnouncementsMabwell reshapes board as new directors appointed following retirements4M ago2493
Company AnnouncementsMabwell appoints employee representative director to third board session4M ago2493
Company AnnouncementsMabwell Clarifies Board Composition and Governance Committee Structure4M ago2493
Company AnnouncementsMabwell Revamps Authorised Representation on Hong Kong Bourse4M ago2493Company AnnouncementsMabwell Shareholders Approve Pay Plans, Auditor and New Mandate at 2026 EGM4M ago2493
Company AnnouncementsMabwell Wins FDA Nod for First-in-Class LILRB4/CD3 Bispecific to Treat Blood Cancers4M ago2493